Biomarker– tag –
-
Wearable Electrochemical Biosensors Provide Real-Time Sweat Biomarker Monitoring for Elite Athletes, Revolutionizing Exercise Management
Omnicuris India Overview Wearable electrochemical biosensors enable continuous, non-invasive, real-time monitoring of sweat lactate, glucose, sodium, potassium, and cortisol in elite athletes during training. These sensors facilitate imm... -
Nix Biosensors Secures Series A to Integrate Hydration Data Science into Consumer Health Platforms, Expands Sweat Biomarker Research
Biospace USA Overview Nix Biosensors has closed its Series A funding round to advance the integration of its hydration data science into existing consumer health platforms. The funding will also support the exploration of additional swea... -
First-of-its-Kind Hydrogen Biosensor Integrated into “Smart Underwear” Continuously Monitors Flatulence, Offers New Metabolic Insights
Bioanalysis Zone UK Overview Scientists have developed a pioneering hydrogen biosensor integrated into "Smart Underwear" capable of continuously monitoring flatulence. This non-invasive device provides novel insights into human metabolis... -
Ultrahuman Launches HealthEx PowerPlug: Integrating Wearable Data with Medical Records to Enhance User Health Management
Digital Health News India Overview Ultrahuman has launched the HealthEx PowerPlug, a new feature for its smart ring users that integrates medical records with continuous wearable data. This allows users to view diagnoses, medications, pr... -
Frontiers Reports Sepsis Cytokine Detection Breakthrough: Electrochemical Biosensors Quantify Whole Blood IL-6 in 5 Minutes with 1 pg/mL Sensitivity
Frontiers Switzerland Overview A perspective article in Frontiers highlights the potential of electrochemical biosensors for rapid and precise quantification of cytokine concentrations in sepsis diagnosis and monitoring. Optimized sensor... -
North American Personal Health Intelligence Market Pivots to AI-Powered, Wearable-Driven, Digital Biomarker Ecosystems
Morningstar USA Overview The North American Personal Health Intelligence Platforms market is undergoing a rapid transformation, shifting from basic health tracking to sophisticated, continuously updated, and personalized ecosystems drive... -
Precedence Research Outlines Digital Biomarker Market Growth Driven by Wearables and AI Healthcare
Precedence Research Unknown Overview Precedence Research has published an overview of its market research report, indicating significant growth in the digital biomarker market, primarily fueled by the increasing adoption of wearable devi... -
Beam Therapeutics Pursues Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency, Citing Positive Phase 1/2 Clinical Data
Simply Wall St USA Overview Beam Therapeutics announced updated Phase 1/2 clinical trial data for BEAM-302, its treatment for Alpha-1 Antitrypsin Deficiency (AATD), showing an acceptable safety profile and promising biomarker data indica... -
Max Delbrück Center Research Reveals ‘Quality Over Quantity’ in CAR-T Therapy, Identifying Key Factors for Low-Dose Efficacy to Enable Personalized Treatment and Cost Reduction
Max Delbrück Center for Molecular Medicine Germany Overview A research consortium from the Max Delbrück Center, publishing in "Nature Communications," identified key biological factors influencing CAR-T cell therapy effectiveness at lowe... -
FDA Grants Breakthrough Therapy Designation to JBS-003 (18F-FMISO), First PET Tracer to Guide Radiation De-escalation in HPV-Positive Oropharyngeal Cancer
Cancer Network USA Overview The U.S. FDA has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole [FMISO]), the first hypoxic PET tracer intended to identify tumor hypoxia and guide radiation therapy de-escalation ...
